Barendrecht, Netherlands

Anthonie Willem Langerak

This inventor holds 4 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Erasmus University Rotterdam, Other. Active years: 2004-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthonie Willem Langerak. Retrieved from https://idiyas.com/inventor/anthonie-willem-langerak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2004-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Anthonie Willem Langerak: Innovator in Nucleic Acid Amplification

Introduction

Anthonie Willem Langerak is a notable inventor based in Barendrecht, Netherlands. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid amplification. With a total of four patents to his name, Langerak's work has implications for early diagnosis and treatment of lymphoproliferative disorders.

Latest Patents

Langerak's latest patents focus on nucleic acid amplification primers for PCR-based clonality studies. These inventions are crucial for the early diagnosis of lymphoproliferative disorders. The primers he developed can amplify various rearrangements, including VH-JH IGH and VK-JK IGK rearrangements. They are also designed for the detection of minimal residual disease (MRD). Additionally, Langerak has provided a kit that includes at least one set of these innovative primers.

Career Highlights

Throughout his career, Langerak has worked with esteemed institutions, including Erasmus Universiteit Rotterdam. His research has significantly advanced the understanding and diagnosis of complex diseases through innovative techniques in molecular biology.

Collaborations

Langerak has collaborated with notable professionals in his field, including Jacobus Johannus Maria Van Dongen. These partnerships have further enriched his research and contributions to the scientific community.

Conclusion

Anthonie Willem Langerak's work in nucleic acid amplification has paved the way for advancements in the early diagnosis of lymphoproliferative disorders. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…